Explore more publications!
Africa News Guide
Got News to Share?

Africa News Guide: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Africa News Guide.

March 2026

Mo Tu We Th Fr Sa Su
1
2 3 4 5 6 7 8
9 10 11 12 13 14 15
16 17 18 19 20 21 22
23 24 25 26 27 28 29
30 31

April 2026

Mo Tu We Th Fr Sa Su
1 2 3 4 5
6 7 8 9 10 11 12
13 14 15 16 17 18 19
20 21 22 23 24 25 26
27 28 29 30

May 2026

Mo Tu We Th Fr Sa Su
1 2 3
4 5 6 7 8 9 10
11 12 13 14 15 16 17
18 19 20 21 22 23 24
25 26 27 28 29 30 31

Press releases published on April 13, 2026

Optum/United Healthcare/United Behavioral Health Expands NeuroStar® TMS Coverage to Include Psychiatric Mental Health Nurse Practitioners
Apr. 13, 2026

Optum/United Healthcare/United Behavioral Health Expands NeuroStar® TMS Coverage to Include Psychiatric Mental Health Nurse Practitioners

Indeterminate GlobeNewswire
ALX Oncology Appoints Jeff Knight as Chief Development and Operating Officer
Apr. 13, 2026

ALX Oncology Appoints Jeff Knight as Chief Development and Operating Officer

Indeterminate GlobeNewswire
Septerna Announces Initiation of Phase 1 Clinical Trial of SEP-479, an Oral Small Molecule PTH1R Agonist for the Treatment of Hypoparathyroidism
Apr. 13, 2026

Septerna Announces Initiation of Phase 1 Clinical Trial of SEP-479, an Oral Small Molecule PTH1R Agonist for the Treatment of Hypoparathyroidism

Indeterminate GlobeNewswire
Global Uranium Corp. Announces Completion of Geological Mapping at the Airline Project in Wyoming
Apr. 13, 2026

Global Uranium Corp. Announces Completion of Geological Mapping at the Airline Project in Wyoming

Indeterminate GlobeNewswire
Favorable Results of Ovarian Cancer Study Presented at Annual Society of Gynecological Care Conference
Apr. 13, 2026

Favorable Results of Ovarian Cancer Study Presented at Annual Society of Gynecological Care Conference

Indeterminate GlobeNewswire
Praxis to Showcase Essential3, the First Positive Phase 3 Program in Essential Tremor, at AAN 2026
Apr. 13, 2026

Praxis to Showcase Essential3, the First Positive Phase 3 Program in Essential Tremor, at AAN 2026

Indeterminate GlobeNewswire
Daraxonrasib Demonstrates Unprecedented Overall Survival Benefit in Pivotal Phase 3 RASolute 302 Clinical Trial in Patients with Metastatic Pancreatic Cancer
Apr. 13, 2026

Daraxonrasib Demonstrates Unprecedented Overall Survival Benefit in Pivotal Phase 3 RASolute 302 Clinical Trial in Patients with Metastatic Pancreatic Cancer

Indeterminate GlobeNewswire
NervGen Pharma to Participate in the H.C. Wainwright "HCW@Home" Series and the 2026 Bloom Burton & Co. Healthcare Investor Conference
Apr. 13, 2026

NervGen Pharma to Participate in the H.C. Wainwright "HCW@Home" Series and the 2026 Bloom Burton & Co. Healthcare Investor Conference

Indeterminate GlobeNewswire
DEEP SEA MINERALS CORP. APPOINTS DAN MCCONNELL AS VICE PRESIDENT OF EXPLORATION
Apr. 13, 2026

DEEP SEA MINERALS CORP. APPOINTS DAN MCCONNELL AS VICE PRESIDENT OF EXPLORATION

Indeterminate GlobeNewswire
Allogene Therapeutics Reports Interim Futility Analysis from Pivotal ALPHA3 Trial Showing 58.3% MRD Clearance with Cemacabtagene Ansegedleucel (Cema-Cel) vs. 16.7% in Observation Arm in First-Line Consolidation LBCL
Apr. 13, 2026

Allogene Therapeutics Reports Interim Futility Analysis from Pivotal ALPHA3 Trial Showing 58.3% MRD Clearance with Cemacabtagene Ansegedleucel (Cema-Cel) vs. 16.7% in Observation Arm in First-Line Consolidation LBCL

Indeterminate GlobeNewswire
Fredonia Mining Inc. Grants Stock Options and Formalizes Management Agreements
Apr. 13, 2026

Fredonia Mining Inc. Grants Stock Options and Formalizes Management Agreements

Indeterminate GlobeNewswire
Gelatide Drops Investigated (2026 Report) What Consumers Should Verify Before Buying
Apr. 13, 2026

Gelatide Drops Investigated (2026 Report) What Consumers Should Verify Before Buying

Indeterminate GlobeNewswire
Eclipse Life Sciences Completes Enrollment in Phase 2 Study Evaluating EC-104 for Diabetic Macular Edema (DME)
Apr. 13, 2026

Eclipse Life Sciences Completes Enrollment in Phase 2 Study Evaluating EC-104 for Diabetic Macular Edema (DME)

Indeterminate GlobeNewswire
Ocular Therapeutix™ Announces Additional Positive Week 52 Data from Landmark SOL-1 Phase 3 Trial of AXPAXLI™ in Wet AMD
Apr. 13, 2026

Ocular Therapeutix™ Announces Additional Positive Week 52 Data from Landmark SOL-1 Phase 3 Trial of AXPAXLI™ in Wet AMD

Indeterminate GlobeNewswire
GFG Exercises its Option and Earns 100% in the 6,500-Hectare WWCC Property in the Prolific Timmins Gold District
Apr. 13, 2026

GFG Exercises its Option and Earns 100% in the 6,500-Hectare WWCC Property in the Prolific Timmins Gold District

Indeterminate GlobeNewswire
Leanzene Gummies Examined: 2026 Consumer-Focused Breakdown of Ingredients, Claims & Label Transparency
Apr. 13, 2026

Leanzene Gummies Examined: 2026 Consumer-Focused Breakdown of Ingredients, Claims & Label Transparency

Indeterminate GlobeNewswire
A.I.S. Resources engages Geo Data Solutions GDS Inc. to complete a high-resolution helicopter-borne magnetic survey to support exploration across its St. John Project
Apr. 13, 2026

A.I.S. Resources engages Geo Data Solutions GDS Inc. to complete a high-resolution helicopter-borne magnetic survey to support exploration across its St. John Project

Indeterminate GlobeNewswire
Telix and Regeneron Announce Strategic Radiopharma Collaboration
Apr. 13, 2026

Telix and Regeneron Announce Strategic Radiopharma Collaboration

Indeterminate GlobeNewswire
MEXC Doubles Market Share to 9% in Two Years, CoinGecko Reports
Apr. 13, 2026

MEXC Doubles Market Share to 9% in Two Years, CoinGecko Reports

Indeterminate GlobeNewswire

Share us

on your social networks:
Facebook Facebook LinkedIn LinkedIn
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions